Engineering Dual-Target & Multi-Receptor Therapeutics to Achieve Superior Clinical Outcomes
3:45 pm - Wednesday 3rd March 2027
- Enhancing efficacy through simultaneous modulation of complementary pathways
- Overcoming biological limitations associated with traditional single-target approaches
- Unlocking new opportunities through rational polypharmacology and multi-receptor design
